For example, Griffith et al.50 showed loss of IDH1 mutation, accompanied by an IDH2 mutation rising from 2% frequency to clonal driver status in an acute myelogenous leukaemia (AML) patient, similar to our findings for p53 in cancer #11. The gene discussed is TP53; the disease is acute myeloid leukemia.